These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 6315231

  • 1. Phase II evaluation of vindesine in non-small cell bronchogenic carcinoma.
    Hutcheon AW, Palmer JB, Pratt MA, Clark RA.
    Cancer Treat Rep; 1983 Nov; 67(11):1041-2. PubMed ID: 6315231
    [No Abstract] [Full Text] [Related]

  • 2. Vindesine in bronchogenic carcinoma: a phase II trial.
    Vogelzang NJ, Peterson BA, Kennedy BJ, Vosika GJ, Conroy JA.
    Am J Clin Oncol; 1982 Feb; 5(1):41-4. PubMed ID: 6282107
    [Abstract] [Full Text] [Related]

  • 3. [Phase II study of vindesine in patients with primary bronchogenic carcinoma by Cooperative Study Group].
    Gan To Kagaku Ryoho; 1983 Aug; 10(8):1838-43. PubMed ID: 6882007
    [Abstract] [Full Text] [Related]

  • 4. A phase II trail of vindesine in patients with refractory small-cell carcinoma of the lung.
    Fuks JZ, Aisner J, Carney DN, Van Echo DA, Ostrow SS, Ihde DC, Wiernik PH.
    Am J Clin Oncol; 1982 Feb; 5(1):49-52. PubMed ID: 6282108
    [Abstract] [Full Text] [Related]

  • 5. Vindesine in the treatment of small cell anaplastic bronchogenic carcinoma.
    Osterlind K, Dombernowsky P, Sørensen PG, Hansen HH.
    Cancer Treat Rep; 1981 Feb; 65(3-4):245-8. PubMed ID: 6263469
    [Abstract] [Full Text] [Related]

  • 6. Vindesine in the treatment of squamous cell carcinoma, adenocarcinoma, and large cell carcinoma of the lung.
    Osterlind K, Hørbov S, Dombernowsky P, Rørth M, Hansen HH.
    Cancer Treat Rep; 1982 Feb; 66(2):305-9. PubMed ID: 7055816
    [Abstract] [Full Text] [Related]

  • 7. Phase II evaluation of vindesine in patients with non-small cell carcinoma of the lung.
    Gralla RJ, Raphael BG, Golbey RB, Young CW.
    Cancer Treat Rep; 1979 Aug; 63(8):1343-6. PubMed ID: 225028
    [Abstract] [Full Text] [Related]

  • 8. Phase II trial of vindesine in patients with small cell lung carcinoma.
    Natale RB, Gralla RJ, Wittes RE.
    Cancer Treat Rep; 1981 Aug; 65(1-2):129-31. PubMed ID: 6261946
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Vindesine: an effective agent in the treatment of non-small cell lung cancer.
    Furnas BE, Williams SD, Einhorn LH, Cobleigh MA.
    Cancer Treat Rep; 1982 Sep; 66(9):1709-11. PubMed ID: 7116347
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Phase II study of vindesine in patients with non-small cell lung cancer.
    Fujita J, Saijo N, Eguchi K, Shinkai T, Tominaga K, Sasaki Y, Futami H, Sakurai M, Ishihara J, Takahashi H.
    Jpn J Cancer Res; 1985 Sep; 76(9):902-5. PubMed ID: 2997097
    [Abstract] [Full Text] [Related]

  • 13. Phase II study of divided-dose vinblastine in non-small cell bronchogenic carcinoma.
    Schulman P, Budman DR, Vinciguerra V, Weiselberg L, Abrams S, Degnan T.
    Cancer Treat Rep; 1982 Jan; 66(1):171-2. PubMed ID: 7053253
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of vindesine in patients with refractory small cell lung cancer.
    Chang AY, Witte RS, Tormey DC, Ramirez G.
    Cancer Treat Rep; 1984 Nov; 68(11):1407-8. PubMed ID: 6094003
    [No Abstract] [Full Text] [Related]

  • 15. Phase II trial of vindesine in advanced squamous cell cancer of the head and neck.
    Vogl SE, Camacho FJ, Kaplan BH, O'Donnell MR.
    Cancer Treat Rep; 1984 Mar; 68(3):559-60. PubMed ID: 6704987
    [No Abstract] [Full Text] [Related]

  • 16. Vindesine (VDS) monochemotherapy for non-small cell lung cancer: a report of 45 cases.
    Luedke SL, Luedke DW, Petruska P, Broun GO, Reed G, Leavitt J.
    Cancer Treat Rep; 1982 Jun; 66(6):1409-11. PubMed ID: 7083243
    [Abstract] [Full Text] [Related]

  • 17. Combination chemotherapy with vindesine and cisplatin for refractory small cell bronchogenic carcinoma.
    Chiuten DF, Carr DT, Dhingra HM, Murphy WK, Spitzer G, Umsawasdi T, Bodey GP, Valdivieso M.
    Cancer Treat Rep; 1986 Jun; 70(6):795-6. PubMed ID: 3015403
    [No Abstract] [Full Text] [Related]

  • 18. [A phase II study of vindesine for pretreated non-small cell lung cancer].
    Shimizu E, Nakamura Y, Yamasaki K, Kimura K, Inoue I, Nakahira S, Kawahito K, Tani K, Sone S, Yamashita T.
    Gan To Kagaku Ryoho; 1987 Aug; 14(8):2532-6. PubMed ID: 3039921
    [Abstract] [Full Text] [Related]

  • 19. Phase II evaluation of chlorozotocin in advanced bronchogenic carcinoma.
    Creagan ET, Eagan RT, Fleming TR, Frytak S, Kvols LK, Ingle JN.
    Cancer Treat Rep; 1979 Aug; 63(11-12):2105-6. PubMed ID: 230898
    [No Abstract] [Full Text] [Related]

  • 20. Phase II trial of vindesine in adenocarcinoma of the lung.
    Sledge GW, Clark GM, Von Hoff DD.
    Cancer Treat Rep; 1984 Mar; 68(3):557-8. PubMed ID: 6704986
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.